Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income2,5451,9021,730
Depreciation/depletion------
Non-Cash items----375
Cash taxes paid, supplemental404227144
Cash interest paid, supplemental573609581
Changes in working capital5,5503,9707,945
Total cash from operations8,0955,87210,050
INVESTING
Capital expenditures----(169)
Other investing and cash flow items, total(5029)(6862)(9892)
Total cash from investing(5029)(6862)(10061)
FINANCING
Financing cash flow items(2)451,140
Total cash dividends paid(939)(807)(725)
Issuance (retirement) of stock, net3259.0013
Issuance (retirement) of debt, net(869)1,274--
Total cash from financing(1485)521428
NET CHANGE IN CASH
Foreign exchange effects(76)67116
Net change in cash1,505(402)533
Net cash-begin balance/reserved for future use3,5964,0013,477
Net cash-end balance/reserved for future use5,1023,5964,011
SUPPLEMENTAL INCOME
Depreciation, supplemental------
Cash interest paid, supplemental573609581
Cash taxes paid, supplemental404227144
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.